Showing results (31-40 of 45) with videos related to

Sort By:
Pageof 5
Melanoma Research|September 15, 2015
BRAF mutation analysis in circulating free tumor DNA of melanoma patients treated with BRAF inhibitorsMaria Gonzalez-Cao, Clara Mayo-de-Las-Casas, Miguel A Molina-Vila, et al.
Lung Cancer (Amsterdam, Netherlands)|August 10, 2013
EGFR mutation analysis in sputum of lung cancer patients: a multitechnique studyA Jasmijn Hubers, Daniëlle A M Heideman, Yasushi Yatabe, et al.
Clinical Chemistry|January 13, 2021
Multiplex Detection of Clinically Relevant Mutations in Liquid Biopsies of Cancer Patients Using a Hybridization-Based PlatformAna Giménez-Capitán, Jillian Bracht, Juan José García, et al.
Nature Communications|December 2, 2021
Intermittent BRAF inhibition in advanced BRAF mutated melanoma results of a phase II randomized trialMaria Gonzalez-Cao, Clara Mayo de Las Casas, Juana Oramas, et al.
Molecular Oncology|September 19, 2019
Prospective detection of mutations in cerebrospinal fluid, pleural effusion, and ascites of advanced cancer patients to guide treatment decisionsSergio Villatoro, Clara Mayo-de-Las-Casas, Núria Jordana-Ariza, et al.
JAMA Oncology|April 10, 2020
Assessment of the Feasibility and Safety of Durvalumab for Treatment of Solid Tumors in Patients With HIV-1 Infection: The Phase 2 DURVAST StudyMaria Gonzalez-Cao, Teresa Morán, Judith Dalmau, et al.
Frontiers in Medicine|January 10, 2017
Liquid Biopsy in Non-Small Cell Lung CancerMiguel A Molina-Vila, Clara Mayo-de-Las-Casas, Ana Giménez-Capitán, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 9, 2019
Evolution and Clinical Impact of EGFR Mutations in Circulating Free DNA in the BELIEF TrialMiguel-Angel Molina-Vila, Rolf A Stahel, Urania Dafni, et al.
The New England Journal of Medicine|August 21, 2009
Screening for epidermal growth factor receptor mutations in lung cancerRafael Rosell, Teresa Moran, Cristina Queralt, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 15, 2011
Pretreatment EGFR T790M mutation and BRCA1 mRNA expression in erlotinib-treated advanced non-small-cell lung cancer patients with EGFR mutationsRafael Rosell, Miguel Angel Molina, Carlota Costa, et al.
Pageof 5